Seroflo
Seroflo Price range: $ 110,00 through $ 659,00
Back to products
Seroquel
Seroquel Price range: $ 40,00 through $ 600,00

Serophene

Price range: $ 40,00 through $ 537,00

Serophene is a trusted medication specifically designed to assist women experiencing difficulties with ovulation. This oral treatment works by stimulating the release of essential hormones required for the development and release of a mature egg. It is highly effective for managing conditions such as polycystic ovary syndrome (PCOS) that may hinder regular reproductive cycles. By promoting predictable ovulation, Serophene significantly increases the chances of successful conception for those planning to start a family. This reliable fertility aid is a preferred choice for supporting natural reproductive health and achieving pregnancy goals.

Active substance: Clomiphene
SKU: Serophene Category:
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Serophene belongs to a class of medications known as selective estrogen receptor modulators. It is approved by the U.S. Food and Drug Administration (FDA) for the treatment of ovulatory dysfunction in women who wish to become pregnant. Serophene is available by prescription only and must be administered under proper medical supervision.

Proper understanding of how Serophene functions, its expected clinical effects, and its potential risks ensures safe and effective administration. This reference document outlines key pharmacological parameters, dosing guidelines, safety considerations, and regulatory details.

Attribute Details
Active Ingredient Clomiphene citrate
Therapeutic Class Selective estrogen receptor modulator (SERM) / Ovulation stimulant
Dosage Form Oral tablet
Route of Administration Oral
Primary Purpose Treatment of ovulatory failure in women desiring pregnancy
Prescription Status Prescription (Rx) only

Clinical Overview and Administration

How the drug works

Serophene acts as a selective estrogen receptor modulator (SERM) possessing both estrogenic and anti-estrogenic properties. The primary therapeutic effect stems from its ability to competitively block estrogen receptors located within the hypothalamus and pituitary gland. Under normal physiological conditions, circulating estrogen exerts a negative feedback inhibition on the secretion of gonadotropins. By occupying these receptor sites, clomiphene citrate prevents endogenous estrogen from binding, thereby misleading the pituitary gland into perceiving low circulating estrogen levels. In response, the pituitary gland increases the secretion of gonadotropin-releasing hormone (GnRH), follicle-stimulating hormone (FSH), and luteinizing hormone (LH). The elevation of FSH stimulates the growth and maturation of ovarian follicles, while the subsequent LH surge triggers ovulation.

Main uses

Serophene is FDA-approved for the treatment of ovulatory failure in women seeking pregnancy, provided that specific clinical criteria are met. It is indicated primarily for individuals experiencing anovulatory infertility, such as patients diagnosed with polycystic ovary syndrome (PCOS) or hypothalamic amenorrhea, provided ovarian function and pituitary responsiveness are intact. Before initiating treatment, prescribers evaluate candidates to exclude organic causes of infertility, including pituitary tumors, primary ovarian failure, or tubal blockages. It is important to note that use of Serophene for male infertility (such as idiopathic oligospermia) is considered an off-label use. FDA approval is strictly limited to female ovulatory dysfunction, and off-label usage should only occur under specialized clinical direction.

Dosing schedule

Dosing regimens for Serophene are individualized based on clinical response and tolerability. The recommended starting dose for the first course of treatment is 50 mg orally once daily for 5 consecutive days. Therapy is typically initiated on or near the fifth day of the menstrual cycle, though treatment may begin at any time in patients who have no recent uterine bleeding. If ovulation occurs at the 50 mg dose, there is no clinical benefit to increasing the dosage in subsequent cycles. If ovulation does not occur after the initial course, a second course of 100 mg daily for 5 days may be administered after appropriate medical evaluation. Doses exceeding 100 mg daily or treatment durations longer than 5 days per cycle are generally not recommended due to increased risk of toxicity without proven efficacy gains.

How it’s absorbed and eliminated

Clomiphene citrate is readily absorbed from the gastrointestinal tract after oral administration. The compound consists of two stereoisomers: enclomiphene and zuclomiphene. Pharmacokinetic profiles indicate that enclomiphene is cleared rapidly from the systemic circulation, whereas zuclomiphene is cleared much more slowly and undergoes significant enterohepatic recirculation. Consequently, detectable levels of drug components or their metabolites can persist in the body for several weeks following administration. Metabolism occurs primarily in the liver, where the active drug undergoes biotransformation. Excretion takes place predominantly through the feces, with a smaller portion cleared via renal pathways in the urine. The mean biological half-life of clomiphene citrate is reported to be approximately 5 to 7 days.

Compatibility with other medicines

Formal drug-drug interaction studies for Serophene are limited, but clinical evaluation requires caution when co-administering with other endocrine therapies. Combining Serophene with other ovulation-inducing agents, such as gonadotropins or aromatase inhibitors, requires meticulous clinical monitoring due to a significantly heightened risk of ovarian hyperstimulation syndrome (OHSS). In addition, medications that affect liver enzyme activity could theoretically alter the metabolism of clomiphene isomers. Patients must inform their healthcare provider of all prescription drugs, over-the-counter medications, dietary supplements, and botanical products currently being taken. Evaluating potential interaction profiles before commencing therapy minimizes adverse systemic effects and helps maintain predictable pharmacological activity throughout the ovulation induction cycle.

Adverse reactions

Adverse reactions associated with Serophene therapy are generally dose-dependent and reversible upon treatment discontinuation. The most frequently observed clinical event is ovarian enlargement, accompanied by pelvic or abdominal discomfort. Vasomotor symptoms, commonly referred to as hot flashes, affect a notable percentage of patients but typically resolve after the five-day treatment course ends. Gastrointestinal symptoms including nausea, vomiting, and abdominal distension are also reported. Visual disturbances, such as blurred vision, scotomas, or photophobia, occur in some individuals and require immediate medical re-evaluation. Other reported side effects include mastalgia (breast tenderness), headache, mood alterations, insomnia, and dermatological symptoms such as transient rashes or mild hair thinning.

Important precautions

Serophene is strictly contraindicated in pregnant women, as animal studies and clinical data indicate potential fetal harm; pregnancy status must be verified prior to each treatment cycle. The drug is also contraindicated in individuals with active liver disease, uncontrolled thyroid or adrenal dysfunction, abnormal uterine bleeding of unknown etiology, or ovarian cysts not related to polycystic ovary syndrome. A key risk associated with clomiphene therapy is multiple gestation (e.g., twins or triplets), which carries inherent maternal and fetal risks. Patients must be monitored for signs of Ovarian Hyperstimulation Syndrome (OHSS), a potentially severe medical condition characterized by rapid fluid shifts, severe pelvic pain, and abdominal distension.

First days of treatment

During the initial days of taking Serophene, physical changes may be subtle. Most patients do not experience immediate systemic symptoms, though mild vasomotor flushes or minor abdominal sensations may emerge as gonadotropin secretion increases. Ovulation typically occurs 5 to 10 days following the completion of the 5-day oral regimen. Baseline ultrasound examinations or basal body temperature monitoring may be utilized by clinical teams to track follicular development. Patients are advised to monitor for severe pelvic tightness, sudden abdominal distension, or visual changes early in the cycle, reporting any unexpected manifestations to their prescribing physician.

If you skip a dose

If a dose of Serophene is missed during the 5-day treatment cycle, the prescribing clinician should be contacted promptly for instructions. Generally, taking a double dose to make up for a missed pill is not recommended, as this increases the likelihood of side effects without improving ovulation outcomes. Depending on when the omission is noticed, the provider may advise taking the missed tablet immediately or adjusting the calendar for the remainder of the cycle. Maintaining a consistent daily administration schedule is vital to achieving the therapeutic hormonal surge necessary for successful follicle stimulation.

Storage and expiration

Serophene tablets should be stored at controlled room temperature, ideally between 59°F and 86°F (15°C to 30°C). The medication must be kept in its original packaging, protected from light, moisture, and excessive heat. Storage in humid environments, such as bathroom medicine cabinets, should be avoided. Keep out of reach of children and pets. Do not use tablets past the expiration date printed on the packaging. Unused or expired medication should be disposed of in accordance with local pharmaceutical waste disposal guidelines or drug take-back programs, rather than flushed down domestic drains.

Red flags

Immediate medical evaluation is necessary if severe adverse reactions develop during or following Serophene administration. Urgent clinical attention is required if patients experience signs of severe Ovarian Hyperstimulation Syndrome, including acute pelvic pain, severe abdominal swelling, sudden weight gain, dyspnea, or reduced urinary output. Visual disturbances, such as persistent blurry vision, spots in the visual field, or double vision, demand immediate cessation of the drug and medical assessment. Any signs of an allergic reaction–such as facial swelling, hives, or difficulty breathing–warrant emergency medical care in an acute setting.

Frequently Asked Questions and Important Disclaimers

1. How long can a patient safely take Serophene?

Clinical guidelines generally restrict Serophene therapy to a maximum of 3 to 6 ovulatory cycles. Continued use beyond 6 cycles is not recommended if pregnancy has not occurred, as cumulative efficacy decreases while the risk of potential complications may rise.

2. What is the risk of having twins or multiple births with Serophene?

Treatment with Serophene carries an increased probability of multiple gestation compared to natural conception. Clinical trial data indicate that approximately 5% to 10% of pregnancies resulting from clomiphene therapy are twin pregnancies, with higher-order multiples (triplets or more) occurring far less frequently.

3. Can Serophene be taken with food?

Yes, Serophene may be administered with or without food. Taking the dose alongside a meal or light snack may help diminish mild gastrointestinal symptoms, such as nausea or stomach upset.

4. What should be done if visual symptoms develop while taking Serophene?

If visual disturbances such as blurred vision, spots, or light sensitivity occur, the medication should be discontinued immediately, and the healthcare provider notified. In most instances, visual symptoms resolve after stopping the drug, but prompt medical evaluation is necessary.

In accordance with FDA requirements.

This material is educational. Only a licensed prescriber can determine whether a medication is appropriate for you.

Additional information
Dosage

25mg

,

50mg

,

100mg

Package

30 pills

,

60 pills

,

90 pills

,

120 pills

,

180 pills

,

270 pills

,

360 pills

Ενεργός Ουσία